FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's original application for a generic aspirin and extended-release dipyridamole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Aspirin and extended-release dipyridamole (Aspirin and extended-release dipyridamole)

Snippet

ORIG AP for ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)